The U.S. government is engaged in the full spectrum of product development from discovery to delivery. It is in the unique position to characterize emerging public health problems, foster innovation, conduct research and establish unique partnerships to introduce life saving products to global populations for improved health. Most biotechnology companies are unaware of the untapped, powerful and comprehensive potential for partnering with government scientists or agencies around R&D, market research and product uptake or implementation. This session will showcase the breadth of opportunities for public-private partnerships though illustrative case studies from the CDC, the CDC Foundation, FDA, NIH, Carter Center, and the Bill and Melinda Gates Foundation that include partnerships with NGOs, Proctor & Gamble, Google, WHO, big PHARMA and Ministries of Health.